Caricamento...
The association of HDL-apoCIII with coronary heart disease and the effect of statin treatment on it
BACKGROUND: Apolipoprotein CIII (apoCIII) is considered to impair the anti-atherogenic effect of high density lipoprotein (HDL) in coronary heart disease (CHD) patients, and apoCIII content in HDL (HDL-apoCIII) predicts CHD more accurately. However, the relationship between HDL-apoCIII and CHD, and...
Salvato in:
| Pubblicato in: | Lipids Health Dis |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4600316/ https://ncbi.nlm.nih.gov/pubmed/26452348 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12944-015-0129-8 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|